Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / Peptides / NAD+
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Written by Dr. Parmis Mojarab, DO·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

NAD+: evidence, legality and safety

Quick answer

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, marketed as IV infusions and precursor supplements for energy and 'longevity.' It is not an approved drug for anti-aging, and rigorous human evidence for the marketed longevity and performance claims is limited.

Regulatory statusA coenzyme sold as an IV therapy and supplement; marketed longevity claims are largely unproven.

What the evidence shows

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, marketed as IV infusions and precursor supplements for energy and 'longevity.' It is not an approved drug for anti-aging, and rigorous human evidence for the marketed longevity and performance claims is limited.

Human clinical evidence

Precursor supplements (NR, NMN) raise NAD+ markers in small trials; durable clinical-outcome benefits in healthy adults are not established.

Animal and laboratory evidence

Substantial preclinical interest in NAD+ metabolism and aging; translation to human outcomes is unproven. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

Known and potential risks

IV administration carries infusion risks; supplement quality varies; NMN's regulatory status as a supplement has been contested.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Status in sport

Not generally prohibited, but verify product contents.

Frequently asked questions

Is NAD+ FDA-approved?

A coenzyme sold as an IV therapy and supplement; marketed longevity claims are largely unproven.

Is there human evidence for NAD+?

Precursor supplements (NR, NMN) raise NAD+ markers in small trials; durable clinical-outcome benefits in healthy adults are not established.

Is NAD+ legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is NAD+ banned in sport?

Not generally prohibited, but verify product contents.

Sources

  1. U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
  2. World Anti-Doping Agency (WADA) Prohibited List — current edition.
  3. Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.